Huntington National Bank’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$401 Buy
14
+13
+1,300% +$413 ﹤0.01% 2651
2026
Q1
$31 Sell
1
-192
-99% -$6.05K ﹤0.01% 3213
2025
Q4
$5.69K Buy
+193
New +$5.36K ﹤0.01% 1960
2025
Q3
– Sell
-40
Closed -$960 – 4193
2025
Q2
$960 Hold
40
– – ﹤0.01% 2350
2025
Q1
$916 Sell
40
-478
-92% -$11.5K ﹤0.01% 2375
2024
Q4
$13.1K Buy
+518
New +$13.1K ﹤0.01% 1675
2024
Q3
– Sell
-2,998
Closed -$88.9K – 4206
2024
Q2
$88.9K Sell
2,998
-574
-16% -$15.9K ﹤0.01% 902
2024
Q1
$108K Buy
+3,572
New +$99.1K ﹤0.01% 870
2023
Q3
– Sell
-50
Closed -$1.95K – 3902
2023
Q2
$1.95K Buy
+50
New +$1.96K ﹤0.01% 2028

Other funds holding RTO

Huntington National Bank's RTO Position: Q2 2026 in Review

Huntington National Bank increased its Rentokil (RTO) stake by 1,300% in Q2 2026, buying an estimated $413 and bringing the position to 14 shares worth $401. The position accounts for ﹤0.01% of the portfolio, ranked #2651.

Huntington National Bank first reported a position in RTO in Q2 2023 and has held it in 9 quarters since. The position peaked at $108K in Q1 2024. 284 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • Huntington National Bank held 14 shares of Rentokil worth $401 as of Q2 2026.
  • Huntington National Bank bought 13 Rentokil shares in Q2 2026, an estimated $413.
  • Rentokil made up ﹤0.01% of Huntington National Bank's portfolio in Q2 2026, its #2651 holding.
  • Huntington National Bank first reported a position in Rentokil in Q2 2023 and has held it in 9 quarters since.
  • Huntington National Bank's Rentokil position peaked at $108K in Q1 2024.
  • 284 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Huntington National Bank's 13F filing for Q2 2026, filed 13 Aug 2026.